|
1
|
Lowin T and Straub RH: Synovial
fibroblasts integrate inflammatory and neuroendocrine stimuli to
drive rheumatoid arthritis. Expert Rev Clin Immunol. 11:1069–1071.
2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ
and Xu J: Rheumatoid arthritis: Pathological mechanisms and modern
pharmacologic therapies. Bone Res. 6(15)2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Lehmann J, Jüngel A, Lehmann I, Busse F,
Biskop M, Saalbach A, Emmrich F and Sack U: Grafting of fibroblasts
isolated from the synovial membrane of rheumatoid arthritis (RA)
patients induces chronic arthritis in SCID mice-A novel model for
studying the arthritogenic role of RA fibroblasts in vivo. J
Autoimmun. 15:301–313. 2000.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Leblond A, Allanore Y and Avouac J:
Targeting synovial neoangiogenesis in rheumatoid arthritis.
Autoimmun Rev. 16:594–601. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Picerno V, Ferro F, Adinolfi A, Valentini
E, Tani C and Alunno A: One year in review: The pathogenesis of
rheumatoid arthritis. Clin Exp Rheumatol. 33:551–558.
2015.PubMed/NCBI
|
|
6
|
Andrii IR and James D: The three
dimensions of somatic evolution: Integrating the role of genetic
damage, life history traits and aging in carcinogenesis. Evol Appl:
Mar 9, 2020 (Epub ahead of print). doi: 10.1111/eva.12947.
|
|
7
|
Foretz M, Guigas B and Viollet B:
Understanding the glucoregulatory mechanisms of metformin in type 2
diabetes mellitus. Nat Rev Endocrinol. 15:569–589. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Braunersreuther V, Viviani GL, Mach F and
Montecucco F: Role of cytokines and chemokines in non-alcoholic
fatty liver disease. World J Gastroenterol. 18:727–735.
2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kotrych D, Dziedziejko V, Safranow K,
Drozdzik M and Pawlik A: CXCL9 and CXCL10 gene polymorphisms in
patients with rheumatoid arthritis. Rheumatol Int. 35:1319–1323.
2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Antonelli A, Rotondi M, Fallahi P,
Romagnani P, Ferrari SM, Barani L, Ferrannini E and Serio M:
Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum
levels in patients with active Graves' disease, and modulation by
methimazole therapy. Clin Endocrinol (Oxf). 64:189–195.
2006.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Rosengren S, Kalunian KC, Kavanaugh A and
Boyle DL: CXCL13 as a marker for outcome of rheumatoid arthritis:
Comment on the article by Meeuwisse et al. Arthritis Rheum.
63:3646–3647. 2011.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yu F, Xie Y, Wang Y, Peng ZH, Li J and
Oupický D: Chloroquine-containing HPMA copolymers as polymeric
inhibitors of cancer cell migration mediated by the CXCR4/SDF-1
chemokine axis. ACS Macro Lett. 5:342–345. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Nanki T, Takada K, Komano Y, Morio T,
Kanegane H, Nakajima A, Lipsky PE and Miyasaka N: Chemokine
receptor expression and functional effects of chemokines on B
cells: Implication in the pathogenesis of rheumatoid arthritis.
Arthritis Res Ther. 11(R149)2009.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Brown MP, Dymock DC, Merritt KA and
Trumble TN: Stromal cell-derived factor-1 (SDF-1) validation using
equine serum, plasma, and synovial fluid. Osteoarthritis Cartilage.
22:S71. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kanbe K, Takemura T, Takeuchi K, Chen Q,
Takagishi K and Inoue K: Synovectomy reduces stromal-cell-derived
factor-1 (SDF-1) which is involved in the destruction of cartilage
in osteoarthritis and rheumatoid arthritis. J Bone Joint Surg Br.
86:296–300. 2004.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Xiang Y, Li Y, Yang L, He Y, Jia D and Hu
X: miR-142-5p as a CXCR4-targeted MicroRNA attenuates SDF-1-induced
chondrocyte apoptosis and cartilage degradation via inactivating
MAPK signaling pathway. Biochem Res Int.
2020(4508108)2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Janssens R, Struyf S and Proost P:
Pathological roles of the homeostatic chemokine CXCL12. Cytokine
Growth Factor Rev. 44:51–68. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wang A, Guilpain P, Chong BF, Chouzenoux
S, Guillevin L, Du Y, Zhou XJ, Lin F, Fairhurst AM, Boudreaux C, et
al: Dysregulated expression of CXCR4/CXCL12 in subsets of patients
with systemic lupus erythematosus. Arthritis Rheum. 62:3436–3446.
2010.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhao LD, Liang D, Wu XN, Li Y, Niu JW,
Zhou C, Wang L, Chen H, Zheng WJ, Fei YY, et al: Contribution and
underlying mechanisms of CXCR4 overexpression in patients with
systemic lupus erythematosus. Cell Mol Immunol. 14:842–849.
2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Karimabad MN, Khoramdelazad H and
Hassanshahi G: Genetic variation, biological structure, sources,
and fundamental parts played by CXCL12 in pathophysiology of type 1
diabetes mellitus. Int J Diabetes Dev Ctries. 37:229–239. 2017.
|
|
21
|
Karouzakis E, Rengel Y, Jüngel A, Kolling
C, Gay RE, Michel BA, Tak PP, Gay S, Neidhart M and Ospelt C: DNA
methylation regulates the expression of CXCL12 in rheumatoid
arthritis synovial fibroblasts. Genes Immun. 12:643–652.
2011.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Medina YF, Ruíz-Gaviria RE, Buitrago-Lopez
A and Villota C: Physical articular examination in the activity of
rheumatoid arthritis: a systematic review of the literature :
Systematic review of the literature regarding physical examination
in rheumatoid arthritis. Clin Rheumatol. 37:1457–1464.
2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Van Thillo A, Vulsteke JB, Van Assche D,
Verschueren P and De Langhe E: Physical therapy in adult
inflammatory myopathy patients: A systematic review. Clin
Rheumatol. 38:2039–2051. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Khalid S, Javad Y and Amir R: Study of
erythrocyte sedimentation rate and anti-cyclic citrullinated
peptide antibodies in rheumatoid arthritis. Pak Armed Forces Med J.
67:283–286. 2017.
|
|
25
|
Varun CN, Raju R, Venkataswamy MM, Ravi V
and Varambally S: Procalcitonin and C-reactive protein as
peripheral inflammatory markers in antipsychotic drug-free
schizophrenia patients. Asian J Psychiatr. 35:11–14.
2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Liao KP: Cardiovascular disease in
patients with rheumatoid arthritis. Trends Cardiovasc Med.
27:136–140. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Albus E, Sinningen K, Winzer M, Thiele S,
Baschant U, Hannemann A, Fantana J, Tausche AK, Wallaschofski H,
Nauck M, et al: Milk fat globule-epidermal growth factor 8 (MFG-E8)
is a novel anti-inflammatory factor in rheumatoid arthritis in mice
and humans. J Bone Miner Res. 31:596–605. 2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Harlow L, Rosas IO, Gochuico BR, Mikuls
TR, Dellaripa PF, Oddis CV and Ascherman DP: Identification of
citrullinated hsp90 isoforms as novel autoantigens in rheumatoid
arthritis-associated interstitial lung disease. Arthritis Rheum.
65:869–879. 2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Crijns H, Vanheule V and Proost P:
Targeting chemokine-glycosaminoglycan interactions to inhibit
inflammation. Front Immunol. 11(483)2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Cutolo P, Basdevant N, Bernadat G,
Bachelerie F and Ha-Duong T: Interaction of chemokine receptor
CXCR4 in monomeric and dimeric state with its endogenous ligand
CXCL12: Coarse-grained simulations identify differences. J Biomol
Struct Dyn. 35:399–412. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Guo F, Wang Y, Liu J, Mok SC, Xue F and
Zhang W: CXCL12/CXCR4: A symbiotic bridge linking cancer cells and
their stromal neighbors in oncogenic communication networks.
Oncogene. 35:816–826. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Chung SH, Seki K, Choi BI, Kimura KB, Ito
A, Fujikado N, Saijo S and Iwakura Y: CXC chemokine receptor 4
expressed in T cells plays an important role in the development of
collagen-induced arthritis. Arthritis Res Ther.
12(R188)2010.PubMed/NCBI View
Article : Google Scholar
|
|
33
|
Armas-González E, Domínguez-Luis MJ,
Díaz-Martín A, Arce-Franco M, Castro-Hernández J, Danelon G,
Hernández-Hernández V, Bustabad-Reyes S, Cantabrana A, Uguccioni M,
et al: Role of CXCL13 and CCL20 in the recruitment of B cells to
inflammatory foci in chronic arthritis. Arthritis Res Ther.
20(114)2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Ding L, Amendola A, Wolf B, Bollier M,
Albright J, Wang Q, Wu M, Wang X, Song H, Pedersen D, et al:
Association of chemokine expression in anterior cruciate ligament
deficient knee with patient characteristics: Implications for
post-traumatic osteoarthritis. Knee. 27:36–44. 2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Wei F, Moore DC, Wei L, Li Y, Zhang G, Wei
X, Lee JK and Chen Q: Attenuation of osteoarthritis via blockade of
the SDF-1/CXCR4 signaling pathway. Arthritis Res Ther.
14(R177)2012.PubMed/NCBI View
Article : Google Scholar
|
|
36
|
De Buck M, Gouwy M, Struyf S, Opdenakker G
and Van Damme J: The ectoenzyme-side of matrix metalloproteinases
(MMPs) makes inflammation by serum amyloid A (SAA) and chemokines
go round. Immunol Lett. 205:1–8. 2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Lin C, Liu L, Zeng C, Cui ZK, Chen Y, Lai
P, Wang H, Shao Y, Zhang H, Zhang R, et al: Activation of mTORC1 in
subchondral bone preosteoblasts promotes osteoarthritis by
stimulating bone sclerosis and secretion of CXCL12. Bone Res.
7(5)2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Kircher M, Herhaus P, Schottelius M, Buck
AK, Werner RA, Wester HJ, Keller U and Lapa C: CXCR4-directed
theranostics in oncology and inflammation. Ann Nucl Med.
32:503–511. 2018.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Ren C and Duan G: The expression of SDF-1α
and CXCR4 in the peripheral blood patients with rheumatoid
arthritis. West Chin Med J, 2018.
|
|
40
|
Leiblein M, Ponelies N, Johnson T, Marzi
J, Kontradowitz K, Geiger E, Marzi I and Henrich D: Increased
extracellular ubiquitin in surgical wound fluid provides a
chemotactic signal for myeloid dendritic cells. Eur J Trauma Emerg
Surg. 46:153–163. 2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Milenkovic VM, Stanton EH, Nothdurfter C,
Rupprecht R and Wetzel CH: The role of chemokines in the
pathophysiology of major depressive disorder. Int J Mol Sci.
20(20)2019.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Karouzakis E, Gay RE, Michel BA, Gay S and
Neidhart M: DNA hypomethylation in rheumatoid arthritis synovial
fibroblasts. Arthritis Rheum. 60:3613–3622. 2009.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Doody KM, Bottini N and Firestein GS:
Epigenetic alterations in rheumatoid arthritis fibroblast-like
synoviocytes. Epigenomics. 9:479–492. 2017.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Kanbe K, Takagishi K and Chen Q:
Stimulation of matrix metalloprotease 3 release from human
chondrocytes by the interaction of stromal cell-derived factor 1
and CXC chemokine receptor 4. Arthritis Rheum. 46:130–137.
2002.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Nanki T, Hayashida K, El-Gabalawy HS,
Suson S, Shi K, Girschick HJ, Yavuz S and Lipsky PE: Stromal
cell-derived factor-1-CXC chemokine receptor 4 interactions play a
central role in CD4+ T cell accumulation in rheumatoid
arthritis synovium. J Immunol. 165:6590–6598. 2000.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Kanbe K, Chiba J, Inoue Y, Taguchi M and
Yabuki A: SDF-1 and CXCR4 in synovium are associated with disease
activity and bone and joint destruction in patients with rheumatoid
arthritis treated with golimumab. Mod Rheumatol. 26:46–50.
2016.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Diamond P, Labrinidis A, Martin SK,
Farrugia AN, Gronthos S, To LB, Fujii N, O'Loughlin PD, Evdokiou A
and Zannettino AC: Targeted disruption of the CXCL12/CXCR4 axis
inhibits osteolysis in a murine model of myeloma-associated bone
loss. J Bone Miner Res. 24:1150–1161. 2009.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Kamezaki K, Kikushige Y, Numata A,
Miyamoto T, Takase K, Henzan H, Aoki K, Kato K, Nonami A, Kamimura
T, et al: Rituximab does not compromise the mobilization and
engraftment of autologous peripheral blood stem cells in
diffuse-large B-cell lymphoma. Bone Marrow Transplant. 39:523–527.
2007.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Zou S, Zhang D, Xu Z, Wen X and Zhang Y:
JMJD3 promotes the epithelial-mesenchymal transition and migration
of glioma cells via the CXCL12/CXCR4 axis. Oncol Lett.
18:5930–5940. 2019.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Li XQ, Zhang ZL, Tan WF, Sun XJ and Ma H:
Down-regulation of CXCL12/CXCR4 expression alleviates
ischemia-reperfusion-induced inflammatory pain via inhibiting glial
TLR4 activation in the spinal cord. PLoS One.
11(e0163807)2016.PubMed/NCBI View Article : Google Scholar
|
|
51
|
McInnes IB and Schett G: Pathogenetic
insights from the treatment of rheumatoid arthritis. Lancet.
389:2328–2337. 2017.PubMed/NCBI View Article : Google Scholar
|
